American Psychiatric Association A, Association AP (1994) Diagnostic and statistical manual of mental disorders: DSM-IV. American Psychiatric Association, Washington, DC

Bogenschutz MP, Ross S, Bhatt S, Baron T, Forcehimes AA, Laska E, Mennenga SE, O’donnell K, Owens IT, Podrebarac S, Rotrosen J, Tonigan JS, Worth L (2022) Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry 79:953–962

Article  PubMed  PubMed Central  Google Scholar 

Burke MJ, Blumberger DM (2021) Caution at psychiatry’s psychedelic frontier. Nat Med 27:1687–1688

Article  CAS  PubMed  Google Scholar 

Butler M, Jelen L, Rucker J (2022) Expectancy in placebo-controlled trials of psychedelics: if so, so what? Psychopharmacology 239:3047–3055

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carhart-harriS R, Giribaldi B, Watts R, Baker-jones M, Murphy-beiner A, Murphy R, Martell J, Blemings A, Erritzoe D, Nutt DJ (2021) Trial of Psilocybin versus Escitalopram for Depression. N Engl J Med 384:1402–1411

Article  CAS  PubMed  Google Scholar 

Cavanna F, Muller S, De La Fuente LA, Zamberlan F, Palmucci M, Janeckova L, Kuchar M, Pallavicini C, Tagliazucchi E (2022) Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study. Transl Psychiatry 12:307

Article  PubMed  PubMed Central  Google Scholar 

Chi T, Gold JA (2020) A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses. J Neurol Sci 411:116715

Article  CAS  PubMed  Google Scholar 

Danforth AL, Grob CS, Struble C, Feduccia AA, Walker N, Jerome L, Yazar-klosinski B, Emerson A (2018) Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study. Psychopharmacology 235:3137–3148

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dos Santos RG, Osorio FL, RochA JM, Rossi GN, Bouso JC, Rodrigues LS, De OliveirASilveira G, Yonamine M, Hallak JEC (2021) Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder: A Pilot, Proof-of-Concept, Randomized, Placebo-Controlled Trial. J Clin Psychopharmacol 41:540–550

Article  PubMed  Google Scholar 

Ettman CK, Abdalla SM, Cohen GH, Sampson L, Vivier PM, Galea S (2020) Prevalence of Depression Symptoms in US Adults Before and During the COVID-19 Pandemic. JAMA Netw Open 3:e2019686

Article  PubMed  PubMed Central  Google Scholar 

Gasser P, Holstein D, Michel Y, Doblin R, Yazar-klosinski B, Passie T, Brenneisen R (2014) Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. J Nerv Ment Dis 202:513–520

Article  PubMed  PubMed Central  Google Scholar 

Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC, Bird C, Blom RE, Brennan C, Brusch D, Burke L, Campbell-coker K, Carhart-harris R, Cattell J, Daniel A, Debattista C, Dunlop BW, Eisen K, Feifel D, Forbes M, Haumann HM, Hellerstein DJ, Hoppe AI, Husain MI, Jelen LA, Kamphuis J, Kawasaki J, Kelly JR, Key RE, Kishon R, Knatz Peck S, Knight G, Koolen MHB, Lean M, Licht RW, Maples-keller JL, Mars J, Marwood L, Mcelhiney MC, Miller TL, Mirow A, Mistry S, Mletzko-crowe T, Modlin LN, Nielsen RE, Nielson EM, Offerhaus SR, O’keane V, Palenicek T, Printz D, Rademaker MC, Vanreemst A, Reinholdt F, Repantis D, Rucker J, Rudow S, Ruffell S, Rush AJ, Schoevers RA, Seynaeve M, Shao S, Soares JC, Somers M, Stansfield SC, Sterling D, Strockis A, Tsai J, Visser L, Wahba M, Williams S, Young AH, Ywema P, Zisook S, Malievskaia E (2022) Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. N Engl J Med 387:1637–1648

Article  CAS  PubMed  Google Scholar 

Griffiths RR, Richards WA, Mccann U, Jesse R (2006) Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology (Berl) 187:268–83 (discussion 284-92)

Article  CAS  PubMed  Google Scholar 

Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, Klinedinst MA (2016) Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J Psychopharmacol 30:1181–1197

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grob CS, Danforth AL, Chopra GS, Hagerty M, Mckay CR, Halberstadt AL, Greer GR (2011) Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch Gen Psychiatry 68:71–78

Article  CAS  PubMed  Google Scholar 

Gully BJ, Eaton E, Capone C, Haass-koffler CL (2023) Treating posttraumatic stress disorder and alcohol use disorder comorbidity: Current pharmacological therapies and the future of MDMA-integrated psychotherapy. J Psychopharmacol 37:1182–1189

Article  PubMed  Google Scholar 

Holze F, Gasser P, Müller F, Dolder PC, Liechti ME (2023) Lysergic Acid Diethylamide-Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study. Biol Psychiatry 93:215–223

Article  CAS  PubMed  Google Scholar 

Kim GS, Uddin M (2020) Sex-specific and shared expression profiles of vulnerability and resilience to trauma in brain and blood. Biol Sex Differ 11:13

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ko K, Kopra EI, Cleare AJ, Rucker JJ (2023) Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis. J Affect Disord 322:194–204

Article  PubMed  Google Scholar 

Kuypers KPC (2020) The therapeutic potential of microdosing psychedelics in depression. Ther Adv Psychopharmacol 10:2045125320950567

Article  PubMed  PubMed Central  Google Scholar 

Kuypers KP, Ng L, Erritzoe D, Knudsen GM, Nichols CD, Nichols DE, Pani L, Soula A, Nutt D (2019) Microdosing psychedelics: More questions than answers? An overview and suggestions for future research. J Psychopharmacol 33:1039–1057

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leichsenring F, Steinert C, Rabung S, Ioannidis JPA (2022) The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta-analytic evaluation of recent meta-analyses. World Psychiatry 21:133–145

Article  PubMed  PubMed Central  Google Scholar 

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700

Article  PubMed  PubMed Central  Google Scholar 

Luoma JB, Chwyl C, Bathje GJ, Davis AK, Lancelotta R (2020) A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy. J Psychoactive Drugs 52:289–299

Article  PubMed  PubMed Central  Google Scholar 

Mitchell JM, BogenschutZ M, Lilienstein A, Harrison C, Kleiman S, Parker-guilbert K, Ot’alora GM, Garas W, Paleos C, Gorman I, Nicholas C, Mithoefer M, Carlin S, Poulter B, Mithoefer A, Quevedo S, Wells G, Klaire SS, Van Der Kolk B, TzarfatY K, Amiaz R, Worthy R, Shannon S, Woolley JD, Marta C, Gelfand Y, Hapke E, Amar S, Wallach Y, Brown R, HamiltoN S, Wang JB, Coker A, Matthews R, De Boer A, Yazar-klosinski B, Emerson A, Doblin R (2021) MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat Med 27:1025–1033

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Doblin R (2011) The safety and efficacy of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. J Psychopharmacol 25:439–452

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mithoefer MC, MithoefeR AT, Feduccia AA, Jerome L, Wagner M, Wymer J, Holland J, Hamilton S, Yazar-klosinski B, Emerson A, Doblin R (2018) 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Lancet Psychiatry 5:486–497

Article  PubMed  Google Scholar 

Moreno FA, Wiegand CB, Taitano EK, Delgado PL (2006) Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. J Clin Psychiatry 67:1735–1740

Article  CAS  PubMed  Google Scholar 

Muthukumaraswamy SD, Forsyth A, Lumley T (2021) Blinding and expectancy confounds in psychedelic randomized controlled trials. Expert Rev Clin Pharmacol 14:1133–1152

Article  CAS  PubMed  Google Scholar 

Oehen P, Traber R, Widmer V, Schnyder U (2013) A randomized, controlled pilot study of MDMA (+/- 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD). J Psychopharmacol 27:40–52

Article  CAS  PubMed  Google Scholar 

Ot’alora GM, Grigsby J, Poulter B, Van Derveer JW III, Giron SG, Jerome L, Feduccia AA, Hamilton S, Yazar-klosinski B, Emerson A, Mithoefer MC, Doblin R (2018) 3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial. J Psychopharmacol 32:1295–1307

Article  Google Scholar 

Palhano-fontes F, Barreto D, Onias H, Andrade KC, Novaes MM, Pessoa JA, Mota-rolim SA, Osório FL, Sanches R, Dos santos RG, Tófoli LF, De Oliveira Silveira G, Yonamine M, RibA J, Santos FR, Silva-junior AA, Alchieri JC, Galvão-coelho NL, Lobão-soares B, Hallak JEC, Arcoverde E, Maia-de-oliveira JP, Araújo DB (2019) Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial. Psychol Med 49:655–663

Article  PubMed  PubMed Central  Google Scholar 

Pull CB (1995) [DSM-IV]. Encephale, 21 Spec No 5, 15–20.

Ross S, Bossis A, Guss J, Agin-liebes G, Malone T, Cohen B, Mennenga SE, Belser A, Kalliontzi K, Babb J, Su Z, Corby P, Schmidt BL (2016) Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol 30:1165–1180